Michael S. Brown - 13 Sep 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**Michael S. Brown
Issuer symbol
REGN
Transactions as of
13 Sep 2021
Net transactions value
-$2,359,108
Form type
4
Filing time
15 Sep 2021, 16:03:54 UTC
Previous filing
10 Aug 2021
Next filing
05 Jan 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $944,375 +2,479 +278% $380.95 3,370 13 Sep 2021 Direct F1
transaction REGN Common Stock Options Exercise $1,493,361 +3,613 +107% $413.33 6,983 13 Sep 2021 Direct F1
transaction REGN Common Stock Options Exercise $1,492,948 +3,612 +52% $413.33 10,595 13 Sep 2021 Direct F1
transaction REGN Common Stock Sale $63,674 -100 -0.94% $636.74 10,495 13 Sep 2021 Direct F1
transaction REGN Common Stock Sale $127,458 -200 -1.9% $637.29 10,295 13 Sep 2021 Direct F1, F2
transaction REGN Common Stock Sale $431,721 -676 -6.6% $638.64 9,619 13 Sep 2021 Direct F1, F3
transaction REGN Common Stock Sale $129,758 -203 -2.1% $639.20 9,416 13 Sep 2021 Direct F1, F4
transaction REGN Common Stock Sale $64,077 -100 -1.1% $640.77 9,316 13 Sep 2021 Direct F1
transaction REGN Common Stock Sale $64,112 -100 -1.1% $641.12 9,216 13 Sep 2021 Direct F1
transaction REGN Common Stock Sale $257,048 -400 -4.3% $642.62 8,816 13 Sep 2021 Direct F1, F5
transaction REGN Common Stock Sale $64,349 -100 -1.1% $643.49 8,716 13 Sep 2021 Direct F1
transaction REGN Common Stock Sale $64,489 -100 -1.1% $644.89 8,616 13 Sep 2021 Direct F1
transaction REGN Common Stock Sale $64,566 -100 -1.2% $645.66 8,516 13 Sep 2021 Direct F1
transaction REGN Common Stock Sale $64,628 -100 -1.2% $646.28 8,416 13 Sep 2021 Direct F1
transaction REGN Common Stock Sale $97,785 -151 -1.8% $647.58 8,265 13 Sep 2021 Direct F1, F6
transaction REGN Common Stock Sale $623,838 -962 -12% $648.48 7,303 13 Sep 2021 Direct F1, F7
transaction REGN Common Stock Sale $544,247 -838 -11% $649.46 6,465 13 Sep 2021 Direct F1, F8
transaction REGN Common Stock Sale $1,170,720 -1,800 -28% $650.40 4,665 13 Sep 2021 Direct F1, F9
transaction REGN Common Stock Sale $2,416,883 -3,712 -80% $651.10 953 13 Sep 2021 Direct F1, F10
transaction REGN Common Stock Sale $40,440 -62 -6.5% $652.26 891 13 Sep 2021 Direct F1
holding REGN Common Stock 5,000 13 Sep 2021 by SLAT F11
holding REGN Common Stock 7,662 13 Sep 2021 by Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -2,479 -100% $0.000000* 0 13 Sep 2021 Common Stock 2,479 $380.95 Direct F1, F12
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -3,613 -50% $0.000000 3,612 13 Sep 2021 Common Stock 3,613 $413.33 Direct F1, F12
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -3,612 -100% $0.000000* 0 13 Sep 2021 Common Stock 3,612 $413.33 Direct F1, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 Represents volume-weighted average price of sales of 200 shares of Company stock on September 13, 2021 at prices ranging from $637.20 to $637.37. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
F3 Represents volume-weighted average price of sales of 676 shares of Company stock on September 13, 2021 at prices ranging from $638.16 to $638.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
F4 Represents volume-weighted average price of sales of 203 shares of Company stock on September 13, 2021 at prices ranging from $639.09 to $639.32. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
F5 Represents volume-weighted average price of sales of 400 shares of Company stock on September 13, 2021 at prices ranging from $642.36 to $642.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
F6 Represents volume-weighted average price of sales of 151 shares of Company stock on September 13, 2021 at prices ranging from $647.42 to $647.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
F7 Represents volume-weighted average price of sales of 962 shares of Company stock on September 13, 2021 at prices ranging from $648.30 to $648.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
F8 Represents volume-weighted average price of sales of 838 shares of Company stock on September 13, 2021 at prices ranging from $649.00 to $649.57. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
F9 Represents volume-weighted average price of sales of 1,800 shares of Company stock on September 13, 2021 at prices ranging from $650.19 to $650.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
F10 Represents volume-weighted average price of sales of 3,712 shares of Company stock on September 13, 2021 at prices ranging from $651.10 to $651.21. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
F11 These shares are held in a trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F12 The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.